Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Endocrine Disease: early-phase trial registry

3 of 5 indexed Endocrine Disease trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Endocrine Disease: 5 US clinical trials tracked, 3 recruiting.

Endocrine Disease is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), running 3 of these trials.

Enrollment posture brief

Registry condition endocrine-disease

OPEN 3 | RECR 60% | LATE 0 | EARLY 3 | RANK #3391 | SPON 3

Volume-matched condition peers

Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Endocrine Disease (this)60%
Open-enrollment share among volume-matched conditions near Endocrine Disease

Endocrine Disease lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Endocrine Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Endocrine Disease is recruiting above its size-band peers.

    3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Endocrine Disease research.

    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Typical Endocrine Disease enrolment sits around 1,000 participants.

    Median target enrolment is 1,000 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.

  4. Endocrine Disease splits between interventional and observational designs.

    3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 21

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 1

Top Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 3 trials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1 trials
M.D. Anderson Cancer Center 1 trials

Named interventions

Most-linked intervention names on Endocrine Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

18-FDG Drug
1 trials
CT scan Device
1 trials
Pentetreotide Drug
1 trials
18F-DOPA Drug
1 trials
Follow Up Behavioral
1 trials
([18F]-6F-DA) Drug
1 trials
([18F]-DOPA) Drug
1 trials
MRI Device
1 trials

US sites by state

Facility locations filed on Endocrine Disease trials. A trial with sites in several states counts in each.

Maryland 4 trials
Texas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Endocrine Disease page

5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Endocrine Disease condition card totals 5 registered trials; most-linked intervention 18-FDG; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.